PerkinElmer Inc. (U.S.)
Eurofins LifeCodexx GmbH (Germany)
COVID-19 Pandemic to Have a Minimal Impact on NIPT Manufacturers
The COVID-19 pandemic has had an adverse effect on several industries across the world. Several reputed companies operating in the non-invasive prenatal testing industry are constantly keeping in touch with the U.S. FDA to get to know detailed information about supply chain disruptions. Also, research institutes are conducting many studies to determine the effect of the coronavirus on births and pregnancies. SeraCare’s report, for instance, declares that clinical testing laboratories and in-vitro diagnostics manufacturers are working closely to determine the interference of SARS-CoV-2 infection on childbirths.
Stem Cell Antibody Market Report Coverage:
Key Growth Factors & Challenges, Segmentation & Regional Outlook, Top Industry Trends & Opportunities, Competition Analysis, COVID-19 Impact Analysis & Projected Recovery, and Market Sizing & Forecast.
Latest launched research on Global
Stem Cell Antibody Market, it provides detailed analysis with presentable graphs, charts and tables. This report covers an in depth study of the Stem Cell Antibody Market size, growth, and share, trends, consumption, segments, application and Forecast 2027. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the global Stem Cell Antibody Market. This report has been prepared by experienced and knowledgeable market analysts and researchers. Each section of the research study is specially prepared to explore key aspects of the global Stem Cell Antibody Market. Buyers of the report will have access to accurate
A recent research study on the global Chemiluminescence Immunoassay Device market presented by Zeal Insider offers a detailed analysis of key market players, market revenue, market segments, share, and geographic regions. It also offers several industry trends and predictions for upcoming Eight years. The report also puts light on the current COVID-19 pandemic situations on the
Global Chemiluminescence Immunoassay Device Market enabling the user to propose strategic growth plans and tactical business judgments. The size of global Chemiluminescence Immunoassay Device market is estimated to grow during the forecast period of 2020 to 2028 with a CAGR of xx% and is estimated to reach.US$ xx million by 2028, from US$ xx million in 2020.
Molecular Diagnostics Market worth $31.8 billion by 2026 - Exclusive Report by MarketsandMarkets Molecular Diagnostics Market by Product & Service(Reagents, Kits, PoC & Tabletop Instruments), Application(COVID-19, Hepatitis, HAI, HIV, Oncology, Genetic Tests), Technology (PCR, NGS, ISH), End User (Hospitals, Diagnostic Labs) - Global Forecast to 2026 , published by MarketsandMarkets, the global market is projected to reach USD 31.8 billion by 2026 from USD 17.8 billion in 2021, at a 12.3% CAGR.
Browse in-depth TOC on
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=833
The increasing prevalence of infectious diseases and cancer, the rising funding for R&D, the increase in PoC testing devices and technological advancements drives growth in the molecular diagnostics market. Emerging economies such as China and Japan are providing lucrative opportunities for the players operating in the market.